Skip to main content

Advertisement

Log in

Melatonin Suppresses Estrogen Deficiency-Induced Osteoporosis and Promotes Osteoblastogenesis by Inactivating the NLRP3 Inflammasome

  • Original Research
  • Published:
Calcified Tissue International Aims and scope Submit manuscript

Abstract

Postmenopausal osteoporosis induced by estrogen deficiency causes inadequate new bone formation and affects millions of women worldwide. Melatonin can improve bone mineral density at the femoral neck in postmenopausal women with osteopenia. This study aimed to investigate the mechanism of melatonin in estrogen deficiency-induced osteoporosis by focusing on osteoblast differentiation. 12-week-old female C57BL/6J mice were ovariectomized (OVX) and intraperitoneally injected with 10 or 50 mg/kg of melatonin for 8 weeks. Micro-computerized tomography scanning demonstrated that melatonin alleviated OVX-induced bone loss in a dose-dependent manner. Serum levels of ALP and osteocalcin (OCN) were further increased, whereas tartrate-resistant acid phosphatase level was decreased by melatonin in OVX-treated mice. Melatonin promoted osteoblast differentiation in primary bone marrow mesenchymal stem cells from OVX mice. It also inhibited activation of NLRP3 inflammasome in femoral bone protein and in induced osteoblasts stimulated by OVX. Knockdown of NLRP3 attenuated OVX-induced repression of osteogenic differentiation. The NLRP3 inflammasome activator monosodium urate partly abrogated the effect of melatonin on the expression of osteoblastogenic markers, including Runx2 and OCN. Additionally, the results showed that melatonin suppressed NLRP3 inflammasome activation by regulating Wnt/β-catenin signaling, which was confirmed by the Wnt/β-catenin inhibitor recombinant DKK1. These results indicated that melatonin ameliorates estrogen deficiency-induced osteoporosis and impaired osteogenic differentiation potential by suppressing activation of the NLRP3 inflammasome via mediating the Wnt/β-catenin pathway.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Rachner TD, Khosla S, Hofbauer LC (2011) Osteoporosis: now and the future. Lancet 377(9773):1276–1287. https://doi.org/10.1016/S0140-6736(10)62349-5

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  2. Krassas GE, Papadopoulou P (2001) Oestrogen action on bone cells. J Musculoskelet Neuronal Interact 2(2):143–151

    PubMed  CAS  Google Scholar 

  3. Liu W, Zhou L, Zhou C, Zhang S, Jing J, Xie L, Sun N, Duan X, Jing W, Liang X, Zhao H, Ye L, Chen Q, Yuan Q (2016) GDF11 decreases bone mass by stimulating osteoclastogenesis and inhibiting osteoblast differentiation. Nat Commun 7:12794. https://doi.org/10.1038/ncomms12794

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  4. Randell KM, Honkanen RJ, Kroger H, Saarikoski S (2002) Does hormone-replacement therapy prevent fractures in early postmenopausal women? J Bone Miner Res 17(3):528–533. https://doi.org/10.1359/jbmr.2002.17.3.528

    Article  PubMed  CAS  Google Scholar 

  5. de Villiers TJ (2015) The role of menopausal hormone therapy in the management of osteoporosis. Climacteric 18(Suppl 2):19–21. https://doi.org/10.3109/13697137.2015.1099806

    Article  PubMed  Google Scholar 

  6. Radogna F, Diederich M, Ghibelli L (2010) Melatonin: a pleiotropic molecule regulating inflammation. Biochem Pharmacol 80(12):1844–1852. https://doi.org/10.1016/j.bcp.2010.07.041

    Article  PubMed  CAS  Google Scholar 

  7. Favero G, Franceschetti L, Bonomini F, Rodella LF, Rezzani R (2017) Melatonin as an anti-inflammatory agent modulating inflammasome activation. Int J Endocrinol 2017:1835195. https://doi.org/10.1155/2017/1835195

    Article  PubMed  PubMed Central  Google Scholar 

  8. Zhang WL, Meng HZ, Yang RF, Yang MW, Sun GH, Liu JH, Shi PX, Liu F, Yang B (2016) Melatonin suppresses autophagy in type 2 diabetic osteoporosis. Oncotarget 7(32):52179–52194. https://doi.org/10.18632/oncotarget.10538

    Article  PubMed  PubMed Central  Google Scholar 

  9. Amstrup AK, Sikjaer T, Heickendorff L, Mosekilde L, Rejnmark L (2015) Melatonin improves bone mineral density at the femoral neck in postmenopausal women with osteopenia: a randomized controlled trial. J Pineal Res 59(2):221–229. https://doi.org/10.1111/jpi.12252

    Article  PubMed  CAS  Google Scholar 

  10. Han Y, Kim YM, Kim HS, Lee KY (2017) Melatonin promotes osteoblast differentiation by regulating osterix protein stability and expression. Sci Rep 7(1):5716. https://doi.org/10.1038/s41598-017-06304-x

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  11. Koyama H, Nakade O, Takada Y, Kaku T, Lau KH (2002) Melatonin at pharmacologic doses increases bone mass by suppressing resorption through down-regulation of the RANKL-mediated osteoclast formation and activation. J Bone Miner Res 17(7):1219–1229. https://doi.org/10.1359/jbmr.2002.17.7.1219

    Article  PubMed  CAS  Google Scholar 

  12. Mundy GR (2007) Osteoporosis and inflammation. Nutr Rev 65(12 Pt 2):S147–S151

    Google Scholar 

  13. Gilbert L, He X, Farmer P, Boden S, Kozlowski M, Rubin J, Nanes MS (2000) Inhibition of osteoblast differentiation by tumor necrosis factor-alpha. Endocrinology 141(11):3956–3964. https://doi.org/10.1210/endo.141.11.7739

    Article  PubMed  CAS  Google Scholar 

  14. Sun X, Hao H, Han Q, Song X, Liu J, Dong L, Han W, Mu Y (2017) Human umbilical cord-derived mesenchymal stem cells ameliorate insulin resistance by suppressing NLRP3 inflammasome-mediated inflammation in type 2 diabetes rats. Stem Cell Res Ther 8(1):241. https://doi.org/10.1186/s13287-017-0668-1

    Article  PubMed  PubMed Central  Google Scholar 

  15. Xu Y, Sheng H, Bao Q, Wang Y, Lu J, Ni X (2016) NLRP3 inflammasome activation mediates estrogen deficiency-induced depression- and anxiety-like behavior and hippocampal inflammation in mice. Brain Behav Immun 56:175–186. https://doi.org/10.1016/j.bbi.2016.02.022

    Article  PubMed  CAS  Google Scholar 

  16. Wang L, Chen K, Wan X, Wang F, Guo Z, Mo Z (2017) NLRP3 inflammasome activation in mesenchymal stem cells inhibits osteogenic differentiation and enhances adipogenic differentiation. Biochem Biophys Res Commun 484(4):871–877. https://doi.org/10.1016/j.bbrc.2017.02.007

    Article  PubMed  CAS  Google Scholar 

  17. Mansoori MN, Shukla P, Kakaji M, Tyagi AM, Srivastava K, Shukla M, Dixit M, Kureel J, Gupta S, Singh D (2016) IL-18BP is decreased in osteoporotic women: prevents Inflammasome mediated IL-18 activation and reduces Th17 differentiation. Sci Rep 6:33680. https://doi.org/10.1038/srep33680

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  18. Cao S, Shrestha S, Li J, Yu X, Chen J, Yan F, Ying G, Gu C, Wang L, Chen G (2017) Melatonin-mediated mitophagy protects against early brain injury after subarachnoid hemorrhage through inhibition of NLRP3 inflammasome activation. Sci Rep 7(1):2417. https://doi.org/10.1038/s41598-017-02679-z

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  19. Cao Z, Fang Y, Lu Y, Tan D, Du C, Li Y, Ma Q, Yu J, Chen M, Zhou C, Pei L, Zhang L, Ran H, He M, Yu Z, Zhou Z (2017) Melatonin alleviates cadmium-induced liver injury by inhibiting the TXNIP-NLRP3 inflammasome. J Pineal Res. https://doi.org/10.1111/jpi.12389

    Article  PubMed Central  PubMed  Google Scholar 

  20. Yang N, Wang G, Hu C, Shi Y, Liao L, Shi S, Cai Y, Cheng S, Wang X, Liu Y, Tang L, Ding Y, Jin Y (2013) Tumor necrosis factor alpha suppresses the mesenchymal stem cell osteogenesis promoter miR-21 in estrogen deficiency-induced osteoporosis. J Bone Miner Res 28(3):559–573. https://doi.org/10.1002/jbmr.1798

    Article  PubMed  CAS  Google Scholar 

  21. Park KH, Kang JW, Lee EM, Kim JS, Rhee YH, Kim M, Jeong SJ, Park YG, Kim SH (2011) Melatonin promotes osteoblastic differentiation through the BMP/ERK/Wnt signaling pathways. J Pineal Res 51(2):187–194. https://doi.org/10.1111/j.1600-079X.2011.00875.x

    Article  PubMed  CAS  Google Scholar 

  22. Chen EEM, Zhang W, Ye CCY, Gao X, Jiang LLJ, Zhao TTF, Pan ZZJ, Xue DDT (2017) Knockdown of SIRT7 enhances the osteogenic differentiation of human bone marrow mesenchymal stem cells partly via activation of the Wnt/beta-catenin signaling pathway. Cell Death Dis 8(9):e3042. https://doi.org/10.1038/cddis.2017.429

    Article  PubMed  PubMed Central  Google Scholar 

  23. Yue S, Zhu J, Zhang M, Li C, Zhou X, Zhou M, Ke M, Busuttil RW, Ying QL, Kupiec-Weglinski JW, Xia Q, Ke B (2016) The myeloid heat shock transcription factor 1/beta-catenin axis regulates NLR family, pyrin domain-containing 3 inflammasome activation in mouse liver ischemia/reperfusion injury. Hepatology 64(5):1683–1698. https://doi.org/10.1002/hep.28739

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  24. Feng J, Sun Q, Liu L, Xing D (2015) Photoactivation of TAZ via Akt/GSK3beta signaling pathway promotes osteogenic differentiation. Int J Biochem Cell Biol 66:59–68. https://doi.org/10.1016/j.biocel.2015.07.002

    Article  PubMed  CAS  Google Scholar 

  25. Rubin R, Arzumanyan A, Soliera AR, Ross B, Peruzzi F, Prisco M (2007) Insulin receptor substrate (IRS)-1 regulates murine embryonic stem (mES) cells self-renewal. J Cell Physiol 213(2):445–453. https://doi.org/10.1002/jcp.21185

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  26. Feng X, Zhang Y, Xu R, Xie X, Tao L, Gao H, Gao Y, He Z, Wang H (2010) Lipopolysaccharide up-regulates the expression of Fcalpha/mu receptor and promotes the binding of oxidized low-density lipoprotein and its IgM antibody complex to activated human macrophages. Atherosclerosis 208(2):396–405. https://doi.org/10.1016/j.atherosclerosis.2009.07.035

    Article  PubMed  CAS  Google Scholar 

  27. Dalle Carbonare L, Valenti MT, Zanatta M, Donatelli L, Lo Cascio V (2009) Circulating mesenchymal stem cells with abnormal osteogenic differentiation in patients with osteoporosis. Arthritis Rheum 60(11):3356–3365. https://doi.org/10.1002/art.24884

    Article  PubMed  Google Scholar 

  28. Wu XB, Li Y, Schneider A, Yu W, Rajendren G, Iqbal J, Yamamoto M, Alam M, Brunet LJ, Blair HC, Zaidi M, Abe E (2003) Impaired osteoblastic differentiation, reduced bone formation, and severe osteoporosis in noggin-overexpressing mice. J Clin Invest 112(6):924–934. https://doi.org/10.1172/JCI15543

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  29. Charles-Harris M, Koch MA, Navarro M, Lacroix D, Engel E, Planell JA (2008) A PLA/calcium phosphate degradable composite material for bone tissue engineering: an in vitro study. J Mater Sci Mater Med 19(4):1503–1513. https://doi.org/10.1007/s10856-008-3390-9

    Article  PubMed  CAS  Google Scholar 

  30. Zhang P, Liu Y, Wang Y, Zhang M, Lv L, Zhang X, Zhou Y (2017) SIRT6 promotes osteogenic differentiation of mesenchymal stem cells through BMP signaling. Sci Rep 7(1):10229. https://doi.org/10.1038/s41598-017-10323-z

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  31. Ortiz F, Acuna-Castroviejo D, Doerrier C, Dayoub JC, Lopez LC, Venegas C, Garcia JA, Lopez A, Volt H, Luna-Sanchez M, Escames G (2015) Melatonin blunts the mitochondrial/NLRP3 connection and protects against radiation-induced oral mucositis. J Pineal Res 58(1):34–49. https://doi.org/10.1111/jpi.12191

    Article  PubMed  CAS  Google Scholar 

  32. Dong Y, Fan C, Hu W, Jiang S, Ma Z, Yan X, Deng C, Di S, Xin Z, Wu G, Yang Y, Reiter RJ, Liang G (2016) Melatonin attenuated early brain injury induced by subarachnoid hemorrhage via regulating NLRP3 inflammasome and apoptosis signaling. J Pineal Res 60(3):253–262. https://doi.org/10.1111/jpi.12300

    Article  PubMed  CAS  Google Scholar 

  33. Zhang Y, Li X, Grailer JJ, Wang N, Wang M, Yao J, Zhong R, Gao GF, Ward PA, Tan DX, Li X (2016) Melatonin alleviates acute lung injury through inhibiting the NLRP3 inflammasome. J Pineal Res 60(4):405–414. https://doi.org/10.1111/jpi.12322

    Article  PubMed  CAS  Google Scholar 

  34. Son JH, Cho YC, Sung IY, Kim IR, Park BS, Kim YD (2014) Melatonin promotes osteoblast differentiation and mineralization of MC3T3-E1 cells under hypoxic conditions through activation of PKD/p38 pathways. J Pineal Res 57(4):385–392. https://doi.org/10.1111/jpi.12177

    Article  PubMed  CAS  Google Scholar 

  35. Foo C, Frey S, Yang HH, Zellweger R, Filgueira L (2007) Downregulation of beta-catenin and transdifferentiation of human osteoblasts to adipocytes under estrogen deficiency. Gynecol Endocrinol 23(9):535–540. https://doi.org/10.1080/09513590701556483

    Article  PubMed  CAS  Google Scholar 

  36. Ping Z, Hu X, Wang L, Shi J, Tao Y, Wu X, Hou Z, Guo X, Zhang W, Yang H, Xu Y, Wang Z, Geng D (2017) Melatonin attenuates titanium particle-induced osteolysis via activation of Wnt/beta-catenin signaling pathway. Acta Biomater 51:513–525. https://doi.org/10.1016/j.actbio.2017.01.034

    Article  PubMed  CAS  Google Scholar 

  37. Takahashi-Yanaga F, Sasaguri T (2009) Drug development targeting the glycogen synthase kinase-3beta (GSK-3beta)-mediated signal transduction pathway: inhibitors of the Wnt/beta-catenin signaling pathway as novel anticancer drugs. J Pharmacol Sci 109(2):179–183

    Article  PubMed  CAS  Google Scholar 

  38. Ladizesky MG, Boggio V, Cutrera RA, Mondelo N, Mastaglia S, Somoza J, Cardinali DP (2006) Melatonin effect on bone metabolism in rats treated with methylprednisolone. J Pineal Res 40(4):297–304. https://doi.org/10.1111/j.1600-079X.2006.00316.x

    Article  PubMed  CAS  Google Scholar 

  39. Bonar SL, Brydges SD, Mueller JL, McGeough MD, Pena C, Chen D, Grimston SK, Hickman-Brecks CL, Ravindran S, McAlinden A, Novack DV, Kastner DL, Civitelli R, Hoffman HM, Mbalaviele G (2012) Constitutively activated NLRP3 inflammasome causes inflammation and abnormal skeletal development in mice. PLoS ONE 7(4):e35979. https://doi.org/10.1371/journal.pone.0035979

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  40. Qi M, Zhang L, Ma Y, Shuai Y, Li L, Luo K, Liu W, Jin Y (2017) Autophagy maintains the function of bone marrow mesenchymal stem cells to prevent Estrogen deficiency-induced osteoporosis. Theranostics 7(18):4498–4516. https://doi.org/10.7150/thno.17949

    Article  PubMed  PubMed Central  Google Scholar 

  41. Rhee YH, Ahn JC (2016) Melatonin attenuated adipogenesis through reduction of the CCAAT/enhancer binding protein beta by regulating the glycogen synthase 3 beta in human mesenchymal stem cells. J Physiol Biochem 72(2):145–155. https://doi.org/10.1007/s13105-015-0463-3

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Lixia Zhang.

Ethics declarations

Conflict of interest

Lijun Xu, Lixia Zhang, Zhifang Wang, Chong Li, Shan Li, Li Li, Qianying Fan, and Lili Zheng declares that they have no conflict of interest.

Ethical Approval

All applicable international, national, and/or institutional guidelines for the care and use of animals were followed.

Human and Animal Rights and Informed Consent

This study was ethically approved by the Institutional Animal Care and Use Committee of The First Affiliated Hospital of Zhengzhou University and performed in accordance with the criteria defined by the rules of the committee.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Xu, L., Zhang, L., Wang, Z. et al. Melatonin Suppresses Estrogen Deficiency-Induced Osteoporosis and Promotes Osteoblastogenesis by Inactivating the NLRP3 Inflammasome. Calcif Tissue Int 103, 400–410 (2018). https://doi.org/10.1007/s00223-018-0428-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00223-018-0428-y

Keywords

Navigation